News HeadLines – 2012

Lyon and Grenoble, France, October 1st, 2012. Aguettant and PX'Therapeutics join forces to boost their activities
Press release        French version

Grenoble – France, March 13th, 2012. PX'Therapeutics announces EuroNeut-41 Prophylactic HIV Vaccine clinical trial.
PX'Therapeutics is pleased to announce the launching of a Phase 1 clinical trial of a prophylactic vaccine against HIV entitled: "Phase 1, Randomised, Single-centre, Observerblind Clinical Trial of Safety and Immunogenicity of Nasal-prime and Intramuscular Boost Immunisation With EN41-FPA2 HIV Vaccine in Healthy Female Volunteers"
Press release

Euronews innovation video


We will be attending the following events.
Please do not hesitate to come and see us at:

Biopartnering North America - Vancouver, Canada - February 26 – 27th, 2012
BioEurope Spring – Amsterdam, The Netherlands – March 19th-21st, 2012
B4B Connection – Bioproduction - Evry, France – February 8-9th
7èmes Journées Scientifiques du CLARA – Lyon, France – March 20th-21st
PEGS 2012 – Boston, USA – April 30th-May 4th
BIO International Convention – Boston, USA - June 18th-21st
EuroMeDiag International Convention – Montpellier, France – July 5 - 6th
BioSpain – Bilbao, Spain – September 19th-21st
BioPharma Outsourcing – Paris, France – October 24-25th
BioEurope - Hambourg, Germany - November 12-14th
BioFit 2012 – Lille, France - 3rd-4th December